Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
CL · NYSE · Household Products
Colgate-Palmolive (CL) · oqro.io/stocks/CL · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
No open-market purchase by an insider of Colgate-Palmolive was filed in the last 90 days. The latest on record was on Aug 1, 2007.
Since 2006, Colgate-Palmolive insiders reported 7 open-market purchases and 1,414 sales on Forms 4 and 5, with purchases in 1 different year, most recently 2007.
In the last 90 days, 5 insiders of Colgate-Palmolive (CL) reported 6 open-market sales worth $8.03M in total on SEC Form 4. The largest seller by value was Panagiotis Tsourapas, with $2.89M. Many insider sales follow a plan set in advance or cover taxes on stock awards; the filing says what was sold, not the reason.
Yes. Members of Congress disclosed 6 trades in Colgate-Palmolive (CL) in the last 12 months, each reported as a value range on a periodic transaction report. The most recent are from Rep. Kevin Hern (OK01), Rep. Julie Johnson (TX32).
Colgate-Palmolive's next results are expected on Jan 28, 2027, after the market closes. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
$98.85−0.76 (−0.76%)
Close of Nov 18, 2026, vs Nov 17 · end-of-day, not a live quote
+24.6% (+$19.52) from Nov 18, 2025 to Nov 18, 2026 · adjusted daily closes
Adjusted close went from $79.33 on Nov 18, 2025 to $98.85 on Nov 18, 2026 (+24.6%). Disclosed in this range: 9 insider trades, 11 pre-arranged insider sales, 4 Congress trades, and 113 13F position changes for 4 quarters ending in it.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Household Products company based in New York City, New York.
Last 12 months
+24.6%
Market value
$78.6B
S&P 500 +10.6% over the same dates. Prices adjusted for splits and dividends.
Short interest: 18.5M shares sold short (2.3% of shares outstanding), +6.5% vs the previous count, 3.8 days of normal trading to buy them back. FINRA, as of Oct 30, 2026.
Revenue
$5.37B
+4.6% vs the same quarter a year earlier
Free cash flow, last 12 months
$3.79B
This quarter $1.04B, a year earlier $1.11B
Net debt
$5.66B
Debt $7.18B, cash $1.53B, at Sep 30, 2026
Net income, last 12 months
$2.05B
Operating profit covers interest 12.6x
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Oct 30, 2026.
Revenue, fiscal 2025
$20.4B
+1.4% vs the year before
Net income, fiscal 2025
$2.13B
As reported in the annual filing
Shares outstanding
795M
As of Sep 30, 2026
In fiscal 2025 the company spent $1.21B buying back its own shares. Cash actually paid, from its cash-flow statement.
Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Insider selling
Traded Nov 10 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade +0.8% · S&P 500 −2.6% · to Nov 18
Colgate-Palmolive's and Controller sold $402K of Colgate-Palmolive shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Nov 5 · filed 4 days laterNot reported under a pre-arranged trading plan
Since the trade +0.2% · S&P 500 −0.4% · to Nov 18
A Colgate-Palmolive director sold $414K of Colgate-Palmolive shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Nov 5 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade +0.2% · S&P 500 −0.4% · to Nov 18
The CEO of Colgate-Palmolive sold $2.01M of Colgate-Palmolive shares. The filing does not indicate a pre-arranged trading plan.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Insiders of Colgate-Palmolive reported 7 open-market purchases and 1,414 sales since 2006; purchases in 2007.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $64.1M19×19 trades |
| 2025 | — | $1.04M3×3 trades |
| 2024 | — | $61.8M30×30 trades |
| 2023 | — | $35.4M30×30 trades |
| 2022 | — | $37.4M24×24 trades |
| 2021 | — | $34.2M27×27 trades |
| 2020 | — | $77.9M59×59 trades |
| 2019 | — | $111M64×64 trades |
| 2018 | — | $73.6M50×50 trades |
| 2017 | — | $50.9M44×44 trades |
| 2016 | — | $67.6M48×48 trades |
| 2015 | — | $61.5M60×60 trades |
| 2014 | — | $63.7M74×74 trades |
| 2013 | — | $74.7M142×142 trades |
| 2012 | — | $95.8M163×163 trades |
| 2011 | — | $29.5M123×123 trades |
| 2010 | — | $16.9M122×122 trades |
| 2009 | — | $11.5M120×120 trades |
| 2008 | — | $10M86×86 trades |
| 2007 | $468K7×7 trades | $29.2M99×99 trades |
| 2006 | — | $2.45M27×27 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Top officer leaving
“Cahillane advised the Board that he will not stand for reelection to the Board at the Annual Meeting of Stockholders to be held on May 8, 2026, in light of the demands associated with his new position as Chief Executive Officer of The Kraft Heinz Company.”
7 insiders sold ~$25.1M in the 60 days before
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.
Against the S&P 500 over the year
Since Nov 14, 2025, CL is up 27.6% and the index fund is up 9.0%: 19 points ahead of the market. Traders call a stock that beats the index over a period a relative-strength leader.
How much CL moves
End-of-day prices. These figures describe the past year and say nothing about what comes next.
Anyone owning more than 5% must file within days. Structured filings have existed since December 2024, so older stakes that were never amended may be missing.
Written by software from the filings listed below · Nov 13, 2026
4 more points, with the facts they come from, are in OQRO Pro.
Sign up free0 certified in FY2026 Q3, vs 2 a year earlier.
Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.
Short sale volume: 51.6% of the volume reported to FINRA over the last 20 trading days was marked short, above its 1-year average of 48.5%. FINRA daily files, to Nov 18, 2026.
Fails to deliver: 16K shares (about $1.48M) were not delivered on time for settlement on Oct 26, 2026. SEC fails-to-deliver data.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock. Fails to deliver have many causes, including processing delays, and are often resolved within days.
Last results
Oct 30, 2026
Within the 30 days after it, until Nov 29, 2026
Next results, expected
Jan 28, 2027
after the market closes; the date can move until the company confirms it
Purchases after results
Not enough history
From Colgate-Palmolive's own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know Colgate-Palmolive's policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.